STREPTOCOCCAL C5a PEPTIDASE VACCINE
Novel vaccines for use against beta -hemolytic Streptococcus colonization or infection are disclosed. The vaccines contain an immunogenic amount of a variant of streptococcal C5a peptidase (SCP). Also disclosed is a method of protecting a susceptible mammal against beta -hemolytic Streptococcus colonization or infection by administering such a vaccine. Enzymatically inactive SCP, and polynucleotides encoding these SCP proteins are further disclosed.
Attached files:Patents:DK 1,892,298
Inventor(s):
CLEARY PAUL PATRICK [US]; STAFSLIEN DEBORAH K [US]
Type of Offer:
Licensing
« More Pharmaceutical Patents